Clinical Trial Update: TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Participants [Phase 3]

View source ↗

Summary

Clinical trial update indicating continued access to etravirine (ETR) for treatment-experienced HIV-1 infected participants in Phase 3; study completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Hiv-1

Drugs mentioned

• etravirine (etravirine)

Snippet

Sponsor: Janssen Sciences Ireland UC | Conditions: HIV Infections, HIV-1 | Phase 3 | Status: COMPLETED | Results posted: 2021-12-21